🔗 Share this article

Chancellor Reeves has revealed she is planning "specific measures to deal with cost of living challenges" in the forthcoming financial statement.

During an interview with the BBC, she emphasized that reducing inflation is a collective task of both the government and the central bank.

The UK's price growth is expected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Potential Utility Cost Measures

Reports indicate the government could take action to bring down energy bills, for example by cutting the present 5% rate of value-added tax charged on energy supplies.

Another option is to cut some of the regulatory levies currently added to bills.

Fiscal Limitations and Analyst Expectations

The government will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these actions.

The consensus from the majority of analysts is that the Chancellor will have to introduce tax rises or budget cuts in order to fulfill her declared debt limits.

Earlier on the same day, analysis suggested there was a £22 billion deficit for the Treasury chief to resolve, which is at the lower end of forecasts.

"There's a shared job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor informed the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Commitments and Global Concerns

While much of the attention has been on likely tax increases, the chancellor said the most recent data from the fiscal watchdog had not changed her pledge to manifesto promises not to raise rates on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with increasing international and trade concerns for the fiscal tax moves, probably to be directed on those "most able to pay."

International Trade Tensions

Addressing apprehensions about the United Kingdom's economic relations with China she said: "The UK's national security invariably take priority."

Recent declaration by China to increase export controls on critical minerals and other materials that are crucial for high-technology production led US President the US President to propose an further 100% tariff on imports from the Asian country, raising the risk of an full-scale commercial conflict between the two global powers.

The American finance chief labeled the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on considering the American proposal to join its battle with the Asian nation, Reeves said she was "deeply worried" by China's actions and called on the Chinese government "not to put up barriers and limit trade."

She said the decision was "harmful for the global economy and causes further challenges."

"It is my opinion there are sectors where we should challenge Chinese policies, but there are also important prospects to export to China's economy, including financial services and other areas of the economic system. We've got to get that balance right."

The chancellor also affirmed she was working with other major economies "on our own critical minerals approach, so that we are reduced dependence."

NHS Drug Pricing and Investment

The Chancellor also recognized that the price the NHS pays for drugs could increase as a result of ongoing talks with the Trump administration and its pharmaceutical firms, in return for reduced taxes and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or abandoning projects in the United Kingdom, with some attributing the modest returns they are obtaining.

Last month, the government science advisor said the cost the NHS pays for medicines would have to increase to stop companies and drug research funding departing from the United Kingdom.

The Chancellor stated to media: "We have seen because of the payment system, that drug testing, innovative medicines have not been offered in the UK in the extent that they are in other continental states."

"Our aim is to ensure that individuals receiving treatment from the National Health Service are able to access the best life-saving medicines in the globe. And so we are looking at this situation, and... aiming to secure increased capital into Britain."